National Cancer Institute; Notice of Meeting, 65401 [2023-20526]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 183 / Friday, September 22, 2023 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 812Q,
Bethesda, MD 20892, (301) 435–1999,
malaiyandilm@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Brain Injury and Neurovascular
Pathologies Study Section.
Date: October 16–17, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alexander Yakovlev,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206,
MSC 7846, Bethesda, MD 20892, 301–435–
1254, yakovleva@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group; Gene
Regulation in Cancer Study Section.
Date: October 16–17, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manzoor A. Zarger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, (301) 435–
2477, zargerma@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: September 18, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–20524 Filed 9–21–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
National Cancer Institute; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Council of Research Advocates.
The meeting will be a hybrid meeting
held in-person and virtually and will be
open to the public as indicated below,
with attendance limited to space
available. Individuals who plan to
attend in-person or view the virtual
meeting and need special assistance or
other reasonable accommodations,
should notify the Contact Person listed
VerDate Sep<11>2014
16:40 Sep 21, 2023
Jkt 259001
65401
below in advance of the meeting. The
meeting can be accessed from the NIH
Videocast at the following link: https://
videocast.nih.gov.
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
Name of Committee: National Cancer
Institute Council of Research Advocates.
Date: October 4, 2023.
Time: 12:00 p.m. to 3:15 p.m.
Agenda: Welcome and Chairwoman’s
Remarks, NCI Director’s Update, NCI
Updates, and Legislative Update.
Place: Porter Neuroscience Research
Center, National Institutes of Health,
Building 35A, Room 610, 35 Convent Drive,
Bethesda, MD 20892–2580 (Hybrid Meeting).
Contact Person: Amy Williams, Acting
Director, NCI Office of Advocacy Relations,
National Cancer Institute, NIH, 31 Center
Drive, Building 31, Room 10A28, Bethesda,
MD 20892, (240) 781–3406, williaam@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: NCRA: https://
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
60-Day Notice of Proposed Information
Collection: Rental Assistance
Demonstration (RAD) Application
Forms; OMB Control No.: 2577–0278
Dated: September 18, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–20526 Filed 9–21–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
[Docket No. FR–7076–N–16]
Office of the Assistant
Secretary for Public and Indian
Housing, PIH, HUD.
ACTION: Notice.
AGENCY:
HUD is seeking approval from
the Office of Management and Budget
(OMB) for the information collection
described below. In accordance with the
Paperwork Reduction Act, HUD is
requesting comment from all interested
parties on the proposed collection of
information. The purpose of this notice
is to allow for 60 days of public
comment.
DATES: Comments Due Date: November
21, 2023.
ADDRESSES: Interested persons are
invited to submit comments regarding
this proposal. Written comments and
recommendations for the proposed
information collection can be sent
within 60 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 60-day Review—Open
for Public Comments’’ or by using the
search function. Interested persons are
also invited to submit comments
regarding this proposal by name and/or
OMB Control Number and should be
sent to: Colette Pollard for a copy of the
proposed forms or other available
information, Department of Housing and
Urban Development, 451 7th Street SW,
Room 8210, Washington, DC 20410–
5000; telephone 202–402–5534 (this is
not a toll-free number) or email:
PaperworkReductionActOffice@
hud.gov.
FOR FURTHER INFORMATION CONTACT: Leea
Thornton, Office of Policy, Program and
Legislative Initiatives, Department of
Housing and Urban Development, 451
7th Street SW, Washington, DC 20410;
telephone (202–402–6455). This is not a
toll-free number. HUD welcomes and is
prepared to receive calls from
individuals who are deaf or hard of
hearing, as well as individuals with
speech or communication disabilities.
To learn more about how to make an
accessible telephone call, please visit
https://www.fcc.gov/consumers/guides/
telecommunications-relay-service-trs.
Copies of available documents
submitted to OMB may be obtained
from Ms. Thornton.
SUMMARY:
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 88, Number 183 (Friday, September 22, 2023)]
[Notices]
[Page 65401]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20526]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Institute Council of Research Advocates.
The meeting will be a hybrid meeting held in-person and virtually
and will be open to the public as indicated below, with attendance
limited to space available. Individuals who plan to attend in-person or
view the virtual meeting and need special assistance or other
reasonable accommodations, should notify the Contact Person listed
below in advance of the meeting. The meeting can be accessed from the
NIH Videocast at the following link: https://videocast.nih.gov.
Name of Committee: National Cancer Institute Council of Research
Advocates.
Date: October 4, 2023.
Time: 12:00 p.m. to 3:15 p.m.
Agenda: Welcome and Chairwoman's Remarks, NCI Director's Update,
NCI Updates, and Legislative Update.
Place: Porter Neuroscience Research Center, National Institutes
of Health, Building 35A, Room 610, 35 Convent Drive, Bethesda, MD
20892-2580 (Hybrid Meeting).
Contact Person: Amy Williams, Acting Director, NCI Office of
Advocacy Relations, National Cancer Institute, NIH, 31 Center Drive,
Building 31, Room 10A28, Bethesda, MD 20892, (240) 781-3406,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the Institute's/Center's home
page: NCRA: https://deainfo.nci.nih.gov/advisory/ncra/ncra.htm, where
an agenda and any additional information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 18, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-20526 Filed 9-21-23; 8:45 am]
BILLING CODE 4140-01-P
